Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0368820040430040481
Journal of the Korean Neuropsychiatr Association
2004 Volume.43 No. 4 p.481 ~ p.484
Interferon-alpha2b Induced Bipolar Syndrome in Patient with Melanoma: A Case Report.
Hong Soon-Tae

Lee Sun-Young
Bae Jae-Nam
Kang Min-Hee
Kim Chul-Soo
Kim Chul-Eung
Abstract
The use of a high dose regimen of interferon (INF) has recently been demonstrated to benefit patients with malignant melanoma and the use of high dose INF for stage IIB and III melanoma was approved by Food and Drug Administration in 1995. The therapeutic benefits of INF are sometimes hampered by their severe and troublesome adverse effects including depression, mania, and cognitive impairment. The authors report a melanoma patient treated with adjuvant INF-alpha2b who developed a manic-depressive syndrome or mood instability with therapy and we reviewed literatures on mania and mixed affective syndrome associated with INF.
KEYWORD
Interferon, Melanoma, Adverse effect, Mania, Mood instability
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø